Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-13 2:59 pm Sale |
2024-09-30 | 13G | Kinnate Biopharma Inc. KNTE |
Vida Ventures LLC | 0 0.000% |
-2,207,772 (Position Closed) |
Filing History |
| 2024-05-03 5:57 pm Purchase |
2024-02-12 | 13D | Kyverna Therapeutics, Inc. KYTX |
Vida Ventures LLC | 4,777,060 11.100% |
4,777,060 (New Position) |
Filing History |
| 2023-02-13 4:21 pm Sale |
2022-12-31 | 13G | Kinnate Biopharma Inc. KNTE |
Vida Ventures LLC | 2,207,772 5.000% |
-539,661 (-19.64%) |
Filing History |
| 2023-02-10 4:16 pm Sale |
2022-12-31 | 13G | Praxis Precision Medicines, Inc. PRAX |
Vida Ventures LLC | 97,978 3.100% |
-97,978 (-50.00%) |
Filing History |
| 2022-02-10 5:17 pm Purchase |
2021-12-31 | 13G | Kinnate Biopharma Inc. KNTE |
Vida Ventures LLC | 2,747,433 6.300% |
359 (+0.01%) |
Filing History |
| 2021-02-12 5:49 pm Purchase |
2020-12-31 | 13G | Praxis Precision Medicines, Inc. PRAX |
Vida Ventures LLC | 195,955 7.700% |
195,955 (New Position) |
Filing History |
| 2021-02-12 5:40 pm Purchase |
2020-12-31 | 13G | Kinnate Biopharma Inc. KNTE |
Vida Ventures LLC | 2,747,074 6.300% |
2,747,074 (New Position) |
Filing History |